Anti-Human IL6 Recombinant Antibody(Clazakizumab)
-
产品编号
YR1275
-
别名
科研级 Clazakizumab ( 克拉扎珠单抗 ), Anti-IL6 Recombinant Antibody, Research Grade Clazakizumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Clazakizumab ( 克拉扎珠单抗 ), Anti-IL6 Recombinant Antibody, Research Grade Clazakizumab |
Catalog Number | YR1275 |
Molecular Name | Clazakizumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Clazakizumab (formerly ALD518 and BMS-945429), an investigational drug, is an aglycosylated, humanized rabbit monoclonal antibody against interleukin-6.[1] Clazakizumab was developed by Bristol Myers Squib and Alder Biopharmaceuticals. |
CAS Number | 1236278-28-6 |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | IL6[Homo sapiens] |